<?xml version='1.0' encoding='utf-8'?>
<section xmlns="https://code.dccouncil.us/schemas/dc-library" xmlns:codified="https://code.dccouncil.us/schemas/codified" xmlns:codify="https://code.dccouncil.us/schemas/codify" xmlns:xi="http://www.w3.org/2001/XInclude" containing-doc="D.C. Code">
  <num>48-902.04</num>
  <heading>Schedule I enumerated.</heading>
  <text>The controlled substances listed in this section are included in Schedule I, unless and until removed therefrom pursuant to <cite path="§48-902.01">§ 48-902.01</cite>:</text>
  <para>
    <num undesignated="true">(a)</num>
    <para>
      <num>(1)</num>
      <text>Unless specifically excepted or unless listed in another schedule, any of the following opiates, including their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, whenever the existence of these isomers, esters, ethers and salts is possible within the specific chemical designation:</text>
      <para>
        <num>(A)</num>
        <text>Acetylmethadol;</text>
      </para>
      <para>
        <num>(B)</num>
        <text>Allylprodine;</text>
      </para>
      <para>
        <num>(C)</num>
        <text>Alphacetylmethadol (except levo-alphacetylmethadol, also known as levo-alphaacetylmethadol, levomethadyl, accetate, or LAAM);</text>
      </para>
      <para>
        <num>(D)</num>
        <text>Alphameprodine;</text>
      </para>
      <para>
        <num>(E)</num>
        <text>Alphamethadol;</text>
      </para>
      <para>
        <num>(F)</num>
        <text>Benzethidine;</text>
      </para>
      <para>
        <num>(G)</num>
        <text>Betacetylmethadol;</text>
      </para>
      <para>
        <num>(H)</num>
        <text>Betameprodine;</text>
      </para>
      <para>
        <num>(I)</num>
        <text>Betamethadol;</text>
      </para>
      <para>
        <num>(J)</num>
        <text>Betaprodine;</text>
      </para>
      <para>
        <num>(K)</num>
        <text>Clonitazene;</text>
      </para>
      <para>
        <num>(L)</num>
        <text>Dextromoramide;</text>
      </para>
      <para>
        <num>(M)</num>
        <text>Diampromide;</text>
      </para>
      <para>
        <num>(N)</num>
        <text>Diethylthiambutene;</text>
      </para>
      <para>
        <num>(O)</num>
        <text>Difenoxin;</text>
      </para>
      <para>
        <num>(P)</num>
        <text>Dimenoxadol;</text>
      </para>
      <para>
        <num>(Q)</num>
        <text>Dimepheptanol;</text>
      </para>
      <para>
        <num>(R)</num>
        <text>Dimethylthiambutene;</text>
      </para>
      <para>
        <num>(S)</num>
        <text>Dioxaphetylbutyrate;</text>
      </para>
      <para>
        <num>(T)</num>
        <text>Dipipanone;</text>
      </para>
      <para>
        <num>(U)</num>
        <text>Ethylmethylthiambutene;</text>
      </para>
      <para>
        <num>(V)</num>
        <text>Etonitazene;</text>
      </para>
      <para>
        <num>(W)</num>
        <text>Etoxeridine;</text>
      </para>
      <para>
        <num>(X)</num>
        <text>Furethidine;</text>
      </para>
      <para>
        <num>(Y)</num>
        <text>Hydroxypethidine;</text>
      </para>
      <para>
        <num>(Z)</num>
        <text>Ketobemidone;</text>
      </para>
      <para>
        <num>(AA)</num>
        <text>Levomoramide;</text>
      </para>
      <para>
        <num>(BB)</num>
        <text>Levophenacylmorphan;</text>
      </para>
      <para>
        <num>(CC)</num>
        <text>Morpheridine;</text>
      </para>
      <para>
        <num>(DD)</num>
        <text>Noracymethadol;</text>
      </para>
      <para>
        <num>(EE)</num>
        <text>Norlevorphanol;</text>
      </para>
      <para>
        <num>(FF)</num>
        <text>Normethadone;</text>
      </para>
      <para>
        <num>(GG)</num>
        <text>Norpipanone;</text>
      </para>
      <para>
        <num>(HH)</num>
        <text>Phenadoxone;</text>
      </para>
      <para>
        <num>(II)</num>
        <text>Phenampromide;</text>
      </para>
      <para>
        <num>(JJ)</num>
        <text>Phenomorphan;</text>
      </para>
      <para>
        <num>(KK)</num>
        <text>Phenoperidine;</text>
      </para>
      <para>
        <num>(LL)</num>
        <text>Piritramide;</text>
      </para>
      <para>
        <num>(MM)</num>
        <text>Proheptazine;</text>
      </para>
      <para>
        <num>(NN)</num>
        <text>Properidine;</text>
      </para>
      <para>
        <num>(OO)</num>
        <text>Propiram;</text>
      </para>
      <para>
        <num>(PP)</num>
        <text>Racemoramide;</text>
      </para>
      <para>
        <num>(QQ)</num>
        <text>Thiophene;</text>
      </para>
      <para>
        <num>(RR)</num>
        <text>Trimeperidine;</text>
      </para>
      <para>
        <num>(SS)</num>
        <text>Acetyl-Alpha-Methylfentanyl;</text>
      </para>
      <para>
        <num>(TT)</num>
        <text>Alphe-methylfentanyl;</text>
      </para>
      <para>
        <num>(UU)</num>
        <text>Alpha-Methylthiofentanyl;</text>
      </para>
      <para>
        <num>(VV)</num>
        <text>Beta-hydroxyfentanyl;</text>
      </para>
      <para>
        <num>(WW)</num>
        <text>Beta-hydroxy-3-Methylfentanyl;</text>
      </para>
      <para>
        <num>(XX)</num>
        <text>3-Methylfentanyl;</text>
      </para>
      <para>
        <num>(YY)</num>
        <text>3-Methylthiofentanyl;</text>
      </para>
      <para>
        <num>(ZZ)</num>
        <text>MPPP;</text>
      </para>
      <para>
        <num>(AAA)</num>
        <text>Para-flurofentanyl;</text>
      </para>
      <para>
        <num>(BBB)</num>
        <text>PEPAP;</text>
      </para>
      <para>
        <num>(CCC)</num>
        <text>Thiofentanyl; and</text>
      </para>
      <para>
        <num>(DDD)</num>
        <text>Tilidine;</text>
      </para>
    </para>
    <para>
      <num>(2)</num>
      <text>Unless specifically excepted or unless listed in another schedule, any of the following opium derivatives, its salts, isomers, and salts of isomers, whenever the existence of these salts, isomers, and salts of isomers is possible within the specific chemical designation:</text>
      <para>
        <num>(A)</num>
        <text>Acetorphine;</text>
      </para>
      <para>
        <num>(B)</num>
        <text>Acetyldihydrocodeine;</text>
      </para>
      <para>
        <num>(C)</num>
        <text>Benzylmorphine;</text>
      </para>
      <para>
        <num>(D)</num>
        <text>Codeine methylbromide;</text>
      </para>
      <para>
        <num>(E)</num>
        <text>Codeine-N-Oxide;</text>
      </para>
      <para>
        <num>(F)</num>
        <text>Cyprenorphine;</text>
      </para>
      <para>
        <num>(G)</num>
        <text>Desomorphine;</text>
      </para>
      <para>
        <num>(H)</num>
        <text>Dihydromorphine;</text>
      </para>
      <para>
        <num>(I)</num>
        <text>Drotepanol;</text>
      </para>
      <para>
        <num>(J)</num>
        <text>Etorphine (except hydrochloride salt);</text>
      </para>
      <para>
        <num>(K)</num>
        <text>Diacetylated morphine (heroin);</text>
      </para>
      <para>
        <num>(L)</num>
        <text>Hydromorphinol;</text>
      </para>
      <para>
        <num>(M)</num>
        <text>Methyldesorphine;</text>
      </para>
      <para>
        <num>(N)</num>
        <text>Methyldihydromorphine;</text>
      </para>
      <para>
        <num>(O)</num>
        <text>Morphine methylbromide;</text>
      </para>
      <para>
        <num>(P)</num>
        <text>Morphine methylsulfonate;</text>
      </para>
      <para>
        <num>(Q)</num>
        <text>Morphine-N-Oxide;</text>
      </para>
      <para>
        <num>(R)</num>
        <text>Myrophine;</text>
      </para>
      <para>
        <num>(S)</num>
        <text>Nicocodeine;</text>
      </para>
      <para>
        <num>(T)</num>
        <text>Nicomorphine;</text>
      </para>
      <para>
        <num>(U)</num>
        <text>Normorphine;</text>
      </para>
      <para>
        <num>(V)</num>
        <text>Pholcodine; and</text>
      </para>
      <para>
        <num>(W)</num>
        <text>Thebacon;</text>
      </para>
    </para>
    <para>
      <num>(3)</num>
      <text>Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following hallucinogenic substances, its salts, isomers and salts of isomers, whenever the existence of these salts, isomers, and salts of isomers is possible within the specific chemical designation (for purposes of this paragraph only, the term “isomer” includes the optical, position, and geometric isomers):</text>
      <para>
        <num>(A)</num>
        <text>4-bromo-2, 5-dimethoxyamphetamine;</text>
      </para>
      <para>
        <num>(B)</num>
        <text>2, 5 dimethoxyamphetamine;</text>
      </para>
      <para>
        <num>(C)</num>
        <text>4-methoxyamphetamine;</text>
      </para>
      <para>
        <num>(D)</num>
        <text>5-methoxy-3, 4-methylenedioxy amphetamine;</text>
      </para>
      <para>
        <num>(E)</num>
        <text>4-methyl-2,5-dimethoxyamphetamine;</text>
      </para>
      <para>
        <num>(F)</num>
        <text>3,4-methylenedioxyamphetamine [MDA];</text>
      </para>
      <para>
        <num>(G)</num>
        <text>3, 4, 5-trimethoxy amphetamine;</text>
      </para>
      <para>
        <num>(H)</num>
        <text>Bufotenine;</text>
      </para>
      <para>
        <num>(I)</num>
        <text>Diethyltryptamine;</text>
      </para>
      <para>
        <num>(J)</num>
        <text>Dimethyltryptamine;</text>
      </para>
      <para>
        <num>(K)</num>
        <text>Ethylamide analog of phencyclidine, PCE;</text>
      </para>
      <para>
        <num>(L)</num>
        <text>Ibogaine;</text>
      </para>
      <para>
        <num>(M)</num>
        <text>Lysergic acid diethylamide;</text>
      </para>
      <para>
        <num>(N)</num>
        <text>Mescaline;</text>
      </para>
      <para>
        <num>(O)</num>
        <text>Peyote;</text>
      </para>
      <para>
        <num>(P)</num>
        <text>N-ethyl-3-piperidyl benzilate;</text>
      </para>
      <para>
        <num>(Q)</num>
        <text>N-methyl-3-piperidyl benzilate;</text>
      </para>
      <para>
        <num>(R)</num>
        <text>Psilocybin;</text>
      </para>
      <para>
        <num>(S)</num>
        <text>Psilocyn;</text>
      </para>
      <para>
        <num>(T)</num>
        <text>Pyrrolidine analog of phencyclidine, PCPY;</text>
      </para>
      <para>
        <num>(U)</num>
        <text>Thiophene analog of phencyclidine;</text>
      </para>
      <para>
        <num>(V)</num>
        <text>Repealed;</text>
      </para>
      <para>
        <num>(W)</num>
        <text>Parahexyl;</text>
      </para>
      <para>
        <num>(X)</num>
        <text>4-bromo-2,5-dimethoxyphenethylamine;</text>
      </para>
      <para>
        <num>(Y)</num>
        <text>3,4-methylenedioxymethamphetamine [MDMA];</text>
      </para>
      <para>
        <num>(Z)</num>
        <text>Alpha-methyltryptamine (other name: AMT);</text>
      </para>
      <para>
        <num>(AA)</num>
        <text>5-methoxy-N,N-diisopropyltryptamine (other name: 5- MeO-DIPT);</text>
      </para>
      <para>
        <num>(BB)</num>
        <text>2,5-dimethoxy-4-(n)-propylthiophenethylamine (other name: 2C-T-7);</text>
      </para>
      <para>
        <num>(CC)</num>
        <text>2-(2,5-Dimethoxy-4-ethylphenyl)ethanamine (2C-E);</text>
      </para>
      <para>
        <num>(DD)</num>
        <text>2-(2,5-Dimethoxy-4-methylphenyl)ethanamine (2C-D);</text>
      </para>
      <para>
        <num>(EE)</num>
        <text>2-(4-Chloro-2,5-dimethoxyphenyl)ethanamine (2C-C);</text>
      </para>
      <para>
        <num>(FF)</num>
        <text>2-(4-Iodo-2,5-dimethoxyphenyl)ethanamine (2C-I);</text>
      </para>
      <para>
        <num>(GG)</num>
        <text>2-[4-(Ethylthio)-2,5-dimethoxyphenyl]ethanamine (2C-T-2);</text>
      </para>
      <para>
        <num>(HH)</num>
        <text>2-[4-(Isopropylthio)-2,5-dimethoxyphenyl]ethanamine (2C- T-4);</text>
      </para>
      <para>
        <num>(II)</num>
        <text>2-(2,5-Dimethoxyphenyl)ethanamine (2C-H);</text>
      </para>
      <para>
        <num>(JJ)</num>
        <text>2-(2,5-Dimethoxy-4-nitro-phenyl)ethanamine (2C-N); and</text>
      </para>
      <para>
        <num>(KK)</num>
        <text>2-(2,5-Dimethoxy-4-(n)-propylphenyl)ethanamine (2C-P);</text>
      </para>
    </para>
    <para>
      <num>(4)</num>
      <text>Unless specifically excepted or unless listed in another schedule, any material, compound, or mixture, or preparation which contains any quantity of the following substances having a depressant effect on the central nervous system including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:</text>
      <para>
        <num>(A)</num>
        <text>Mecloqualone;</text>
      </para>
      <para>
        <num>(B)</num>
        <text>Methaqualone; and</text>
      </para>
      <para>
        <num>(C)</num>
        <text>Gamma-hydroxybutyric acid (some other names include GHB; gamma-hydroxybutyrate; 4-hydroxybutyrate; 4-hydroxybutanoic acid; sodium oxybate; sodium oxybutyrate);</text>
      </para>
    </para>
    <para>
      <num>(5)</num>
      <text>Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system, including their analogues or derivatives and its salts, isomers, and salts of isomers:</text>
      <para>
        <num>(A)</num>
        <text>Fenethyline;</text>
      </para>
      <para>
        <num>(B)</num>
        <text>N-ethylamphetamine;</text>
      </para>
      <para>
        <num>(C)</num>
        <text>Cathinone;</text>
      </para>
      <para>
        <num>(D)</num>
        <text>N-Benzylpiperazine (some other names: BZP, 1- benzylpiperazine);</text>
      </para>
      <para>
        <num>(E)</num>
        <text>Methcathinone (Some other names: 2-(methylamino)- propiophenone; alpha-(methylamino)propiophenone; 2-(methylamino)-1-phenylpropan-1- one; alpha- -methylaminopropiophenone; monomethylpropion; ephedrone; — methylcathinone; methylcathinone; AL-464; AL-422; AL-463 and UR1432), its salts, optical isomers and salts of optical isomers, as well as synthetic substances, derivatives, and their isomers with similar chemical structure and pharmacological activity to methcathinone;</text>
      </para>
      <para>
        <num>(F)</num>
        <text>4-methyl-N-methylcathinone (other name: mephedrone);</text>
      </para>
      <para>
        <num>(G)</num>
        <text>3,4-methylenedioxypyrovalerone (other name: MDPV); and</text>
      </para>
      <para>
        <num>(H)</num>
        <text>3,4-methylenedioxy-N-methylcathinone (other name: methylone).</text>
      </para>
    </para>
  </para>
  <annotations>
    <annotation doc="D.C. Law 4-29" type="History" path="§204">Aug. 5, 1981, D.C. Law 4-29, § 204, 28 DCR 3081</annotation>
    <annotation type="History">amended by rule, 39 DCR 1882</annotation>
    <annotation type="History">amended by rule, Dec. 7, 1994, 41 DCR 7967</annotation>
    <annotation doc="D.C. Law 13-99" type="History">May 9, 2000, D.C. Law 13-99, § 2(a), 47 DCR 791</annotation>
    <annotation doc="D.C. Law 18-88" type="History">Dec. 10, 2009, D.C. Law 18-88, § 225, 56 DCR 7413</annotation>
    <annotation doc="D.C. Law 19-320" type="History">June 19, 2013, D.C. Law 19-320, § 301(b), 60 DCR 3390</annotation>
    <annotation type="Emergency Legislation">For temporary (90 days) amendment of this section, see § 301(b) of the Omnibus Criminal Code Amendment Congressional Review Emergency Act of 2013 (D.C. Act 20-44, April 1, 2013,  60 DCR 5381, 20 DCSTAT 1281).</annotation>
    <annotation type="Emergency Legislation">For temporary amendment of section, see § 301(b) of the Omnibus Public Safety and Justice Amendment Act of 2012 (D.C. Act 19-599, January 14, 2013,  60 DCR 1017).</annotation>
    <annotation type="Emergency Legislation">For temporary (90 day) amendment of section, see § 225 of Omnibus Public Safety and Justice Congressional Review Emergency Amendment Act of 2009 (D.C. Act 18-227, October 21, 2009,  56 DCR 8668).</annotation>
    <annotation type="Emergency Legislation">For temporary (90 day) amendment of section, see § 225 of Omnibus Public Safety and Justice Emergency Amendment Act of 2009 (D.C. Act 18-181, August 6, 2009,  56 DCR 6903).</annotation>
    <annotation type="Emergency Legislation">For temporary (90-day) amendment of section, see § 2 of the Uniform Controlled Substances Congressional Review Emergency Amendment Act of 1999 (D.C. Act 13-144, October 18, 1999,  46 DCR 9904).</annotation>
    <annotation type="Emergency Legislation">For temporary (90-day) amendment of section, see § 2 of the Uniform Controlled Substances Emergency Amendment Act of 1999 (D.C. Act 13-96, June 15, 1999,  46 DCR 5640).</annotation>
    <annotation type="Temporary Legislation">For temporary (225 day) amendment of section, see § 2 of Uniform Controlled Substances Temporary Amendment Act of 1999 (<cite doc="D.C. Law 13-34">D.C. Law 13-34</cite>, October 7, 1999, law notification  47 DCR 3423).</annotation>
    <annotation type="Effect of Amendments">The 2013 amendment by <cite doc="D.C. Law 19-320">D.C. Law 19-320</cite> added (3)(Z) through (3)(KK); added (4)(C); inserted “their analogues or derivatives and” in the introductory language of (5); added (5)(D) through (5)(H); and made related changes.</annotation>
    <annotation type="Effect of Amendments"><cite doc="D.C. Law 18-88">D.C. Law 18-88</cite>, in par. (5), deleted “and” from the end of subpar. (A), substituted “; and” for a period at the end of subpar. (B), and added subpar. (C).</annotation>
    <annotation type="Effect of Amendments"><cite doc="D.C. Law 13-99">D.C. Law 13-99</cite> corrected the way in which two chemicals were stated in subsec. (3) and added provisions contained in (X) and (Y) in subsec. (3).</annotation>
    <annotation type="Prior Codifications">1981 Ed., § 33-514.</annotation>
    <annotation type="Section References">This section is referenced in <cite path="§7-3002">§ 7-3002</cite>, <cite path="§44-1201">§ 44-1201</cite>, <cite path="§48-901.02">§ 48-901.02</cite>, <cite path="§48-902.01">§ 48-902.01</cite>, <cite path="§48-902.02">§ 48-902.02</cite>, <cite path="§48-1004">§ 48-1004</cite>, and <cite path="§50-2206.13">§ 50-2206.13</cite>.</annotation>
  </annotations>
</section>
